Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Outcomes of Revascularization for Peripheral Artery Disease in Aboriginal and Torres Strait Islander Peoples and Non-Indigenous Australians.

Annals of vascular surgery·2025
Same author

Association of Depression with Walking in People with Peripheral Artery Disease: A Post-Hoc Analysis of the BIP Trial.

Journal of atherosclerosis and thrombosis·2025
Same author

Honoring the Life and Legacy of Dr David A. Dichek.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

A randomised, double-blind, placebo-controlled study to determine the analgesic efficacy, safety and tolerability of VPX638 administered topically to painful wounds.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society·2025
Same author

Unmet Needs and Opportunities for Australian Innovation and Clinical Research to Improve Quality of Life and Outcomes in Patients With Peripheral Artery Disease.

Heart, lung & circulation·2025
Same author

Is incident cancer in later life associated with lower incidence of dementia?

International psychogeriatrics·2025
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Jul 3, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

急性大動脈解剖による.

Jonathan Golledge1, Kim A Eagle

  • 1Vascular Biology Unit, School of Medicine, James Cook University, Townsville, Australia. jonathan.golledge@jcu.edu.au

Lancet (London, England)
|July 8, 2008
PubMed
まとめ
この要約は機械生成です。

急性大動脈解剖の理解は,国際登録や遺伝子研究を通じて進歩しました. 新しい内静脈治療は選択肢を提供しているが,手術は,上昇性大動脈の症例の鍵となっている.

さらに関連する動画

An Approach to Point-Of-Care Ultrasound Evaluation of the Abdominal Aorta
07:12

An Approach to Point-Of-Care Ultrasound Evaluation of the Abdominal Aorta

Published on: September 8, 2023

関連する実験動画

Last Updated: Jul 3, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

An Approach to Point-Of-Care Ultrasound Evaluation of the Abdominal Aorta
07:12

An Approach to Point-Of-Care Ultrasound Evaluation of the Abdominal Aorta

Published on: September 8, 2023

科学分野:

  • 心臓病学 心臓病学
  • 血管外科 血管外科
  • 遺伝学 遺伝学とは

背景:

  • 急性大動脈解剖 (AAD) は,継続的な研究を必要とする生命を脅かす状態です.
  • AADの理解は,国際登録と分子生物学における進歩によって著しく強化されています.
  • 遺伝的要因と結合組織疾患は,AADの病原性において重要な役割を果たします.

研究 の 目的:

  • 急性大動脈解剖の流行病学,プレゼンテーション,病原性,診断,および管理における最近の進歩を要約します.
  • AAD理解に対する国際登録簿と遺伝子研究の影響を強調する.
  • 新興の内血管技術とAAD治療におけるその役割を見直す.

主な方法:

  • 急性大動脈解剖に関する現在の文献の包括的なレビュー.
  • 国際登録からのデータの分析.
  • 結合組織疾患に関連する分子生物学と遺伝学の進歩の評価.
  • 新しい内血管系製品と外科技術の評価.

主要な成果:

  • AADの流行病学とプレゼンテーションを理解する上で,重要な進展がありました.
  • 分子生物学と遺伝学は,AADに関連した結合組織疾患の病原性を明らかにしました.
  • 血管内部の進歩は,新しい治療法を提供している.
  • オープン手術による修復は,上昇性大動脈解剖の主要な治療法です.
  • 血管内部の治療は,他の大動脈のセグメントに限られた解剖のためにますます利用されています.

結論:

  • 継続的な研究と国際登録を通じてデータの共有は,AADのケアを前進させるために不可欠です.
  • 遺伝的洞察は,傾向を理解し,標的療法を開発するために不可欠です.
  • 手術技術と内血管技術を組み合わせたハイブリッドアプローチは,複雑な大動脈解剖の標準になっています.
  • 解剖の種類と患者の要因に基づいて個別化された治療戦略は不可欠です.